Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-11-04, Stock:ABBV, The news for the past five days is as follows:
2019-10-28: NEWS1: Imbruvica to Offset Humira Woes in AbbVie (ABBV) Q3 Earnings?.
2019-10-29: NEWS1: McDonald's, AbbVie nab 2019 Chicago Innovation Awards.NEWS2: AbbVie Launches Let Me Be Clear to Empower People with Psoriasis to Speak Up and Seek Freedom from Their Disease.
2019-10-30: NEWS1: AbbVie (ABBV) Set to Report Q3 Results: Can Things Turnaround?.NEWS2: U.S. lobbying for U.K. drug price rise prompts Johnson, Corbyn clash over post-Brexit trade pact.NEWS3: Why AbbVie (ABBV) is a Great Dividend Stock Right Now.
2019-10-31: NEWS1: AbbVie Has Turned to the Upside So Continue to Hold Longs and Raise Sell Stops.NEWS2: RINVOQ™ (upadacitinib) Meets Primary and All Ranked Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis.NEWS3: AbbVie Reports Earnings Tomorrow. Here’s What to Expect..
2019-11-01: NEWS1: 5 High-Yield Stocks That Can Keep On Giving.NEWS2: AbbVie Stock Jumps On Strong Quarter As Allergan Takeover Looms.NEWS3: S&P500 and Nasdaq hit new records after October jobs numbers beat expectations.NEWS4: 6 Top Stock Trades for Monday: BABA, PINS, CVX.NEWS5: S&P 500, Nasdaq hit new records after October jobs numbers beat expectations.NEWS6: AbbVie (ABBV) Beats on Q3 Earnings & Sales, Tweaks EPS View.NEWS7: Pharma Stock Roundup: MRK, PFE, GSK, BMY Q3 Earnings, Other Updates.NEWS8: AbbVie Stock Jumps On Strong Quarter As Allergan Takeover Looms.NEWS9: WIll Allergan (AGN) Beat Estimates This Earnings Season?.NEWS10: Top Ranked Growth Stocks to Buy for November 1st.NEWS11: AbbVie says multiple parties vying for assets related to Allergan deal approval.NEWS12: AbbVie says multiple parties vying for assets related to Allergan deal approval.NEWS13: AbbVie Hits Another Home Run, Even as Humira Sales Drop.NEWS14: Bristol-Myers (BMY) Hits Fresh High: Is There Still Room to Run?.NEWS15: Should Value Investors Buy AbbVie (ABBV) Stock?.NEWS16: AbbVie (ABBV) Q3 Earnings and Revenues Beat Estimates.NEWS17: AbbVie Delivers on Earnings and Raises Forecast.NEWS18: UPDATE 2-AbbVie 2019 revenue forecast tops Wall Street estimates while it eyes future Botox sales.NEWS19: Is AbbVie (ABBV) a Solid Growth Stock? 3 Reasons to Think &quot; Yes &quot;.NEWS20: AbbVie Reports Q3 Earnings Beat.NEWS21: AbbVie Earnings Top Views, Dividend Hiked.NEWS22: AbbVie beats earnings expectations and raises outlook, boosts dividend by 10%.NEWS23: AbbVie 2019 revenue forecast tops Wall Street estimates while it eyes future Botox sales.NEWS24: AbbVie boosts 2019 profit outlook as Humira helps beat revenue estimates.NEWS25: AbbVie boosts 2019 profit outlook as Humira helps beat revenue estimates.NEWS26: AbbVie Reports Third-Quarter 2019 Financial Results.NEWS27: The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance.NEWS28: AbbVie Rises 3%.NEWS29: UPDATE 1-Novartis arthritis drug falls short in challenge to global bestseller.NEWS30: [video]AbbVie Posts Stronger-Than-Expected Earnings, Lifts Forecast.NEWS31: Stocks: Pinterest Slumps in Premarket; Aibaba, Abbvie, Rise.NEWS32: AbbVie Earnings, Revenue Beat in Q3.

Answer: Rise